Skip to main content
. 2022 Jun 8;40(5):1020–1029. doi: 10.1002/hon.3038

FIGURE 1.

FIGURE 1

Progression‐free survival by IRC in patients ≥70 and <70 years of age, in the intent‐to‐treat population. CI, confidence interval; d, dexamethasone; IRC, Independent Response Committee; Isa, isatuximab; K, carfilzomib